Jump to main content
Jump to site search

All chapters
Previous chapter Next chapter

CHAPTER 13

Non-coding RNA and Multiple Sclerosis: New Targets for Drug Discovery

Non-coding RNA (ncRNA) have been described to take part in several molecular pathways regulating cell functions. Hence, they have been postulated as possible therapeutic targets and mediators in several diseases. Regarding multiple sclerosis, they have been described to be involved in the regulation of the immune response and in remyelination. In this chapter, the role of ncRNA in inflammation and remyelination will be addressed, focusing on their therapeutic potential for multiple sclerosis.

Publication details


Print publication date
28 Jun 2019
Copyright year
2019
Print ISBN
978-1-78801-450-2
PDF eISBN
978-1-78801-607-0
ePub eISBN
978-1-78801-806-7
From the book series:
Drug Discovery